Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery
NCT07140640Phase 4Recruiting
- Sponsor
- Aswan University
- Start
- Sep 2025
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine in cesarean section, sponsored by Aswan University. Started Sep 2025; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
cesarean section
Beyond the preview
Go deeper on NCT07140640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07140640.